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Abstract
Introduction: This review of 25 consecutive patients with Morgellons disease (MD) was undertaken
for two primary and extremely fundamental reasons. For semantic accuracy, there is only one
“proven” MD patient: the child first given that label. The remainder of inclusive individuals adopted
the label based on related descriptions from 1544 through 1884, an internet description quoted from
Sir Thomas Browne (1674), or was given the label by practitioners using similar sources. Until now,
there has been no formal characterization of MD from detailed examination of all body systems. Our
second purpose was to differentiate MD from Delusions of Parasitosis (DP), another “informal” label
that fit most of our MD patients. How we defined and how we treated these patients depended
literally on factual data that would determine outcome. How they were labeled in one sense was
irrelevant, except for the confusing conflict rampant in the medical community, possibly significantly
skewing treatment outcomes.
Case presentation: Clinical information was collected from 25 of 30 consecutive self-defined
patients with Morgellons disease consisting of laboratory data, medical history and physical
examination findings. Abnormalities were quantified and grouped by system, then compared and
summarized, but the numbers were too small for more complex mathematical analysis. The
quantification of physical and laboratory abnormalities allowed at least the creation of a practical
clinical boundary, separating probable Morgellons from non-Morgellons patients. All the 25 patients
studied meet the most commonly used DP definitions.
Conclusions: These data suggest Morgellons disease can be characterized as a physical human illness
with an often-related delusional component in adults. All medical histories support that behavioral
aberrancies onset only after physical symptoms. The identified abnormalities include both immune
deficiency and chronic inflammatory markers that correlate strongly with immune cytokine excess.
The review of 251 current NLM DP references leads us to the possibility that Morgellons disease and
DP are grossly truncated labels of the same illness but with the reversal of the cause-effect order.
Further, the patients’ data suggest that both illnesses have an infectious origin.
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Theterm“Morgellonsdisease”firstpubliclyappearedonthe
Internet in 2002. The “index” case was the first modern case
to which that label was appended: a sick child whose
physicalsignsandsymptomswerecollectivelyunrecognized
as an entity at local and regional medical facilities. As the
child’s illness persisted without recognition or resolution,
the unaffected parent sought similar illness descriptions
from historic medical references,eventually settling on “The
Morgellons”, a label given to childhood cases described in
France in 1674 by Sir Thomas Browne [1]. His description
was limited to its dermal components: hair-like extrusions
and sensations of movement. Ettmuller, a physician,
produced the only known drawings of The Morgellons in
1682 and considered these dermal “filaments” a parasitic
infestation [1]. Numerous isolated descriptions of similar
phenomenawerefoundby Kellettfrom 1544 through1884
that began as a pediatric-only illness identified by posterior
torso“bristles”butalsoincludedextremeagitation,seizures,
“wasting” and death (characteristics not seen in the 21
st
century). By the early 1600s, the illness was thought to be
caused by the parasite Dracunculus (later called Dracontia,
thenpilarisaffectio)an d“cured”byfilament(agent)removal
from the skin. The worm theory was considered debunked
by 1715 when the esteemed microscopist, Leuvenhoeck,
pronounced the bristles “inanimate”. From this point
forward to 1884, however, the illness shifted toward
comedones, facial regions and to adults. And Demodex
folliculorum was considered a frequent occupant of come-
dones, again supporting a “parasite” concept.
Thename“Morgellonsdisease”wasthuscreatedin2002,as
ap r a c t i c a l“place holder” because of its dermal similarity
to The Morgellons described by Browne in particular
(Browne’s The Morgellons label evolved further over three
centuries into the words, “Masquelon”,t h e nMasclous dicti
and Les Crinons, shifting to Comedones after 1800). The
new label also provided an alternative to differentiate a
clearly, non-delusional child from many decades of clinical
use of the label Delusions of Parasitosis [2-10]. This first
set of actions would eventually raise one of the major
philosophical questions of modern medicine: Does
the practice of “evidence-based medicine” come from
peer-reviewed literature, or from the actual patient?
Information from what was later to become the Morgellons
Research Foundation (MRF) website initially provided a
broader look at the believed Morgellons disease symptoms
byallowingpatientregistrantstorecordtheirsymptomsand
signs.Clearly,mostofthe21
stcenturypatientsdidnotfitthe
descriptions from 1500-1800. The MRF website provided a
glimpse of the current global prevalence of those consider-
ingtheyareaffectedbythisphenomenon.OnJanuary2009,
there are 13,000+ family registrants from all U.S. states and
from 15 other countries. [http://www.morgellons.com/]
Given the growing use of the label Morgellons disease,
characterizing the illness using verifiable clinical data
seemed to be the imperative first step for clinicians,
particularly to separate these patients from those two to
five centuries before presentation. Until 2007, Morgellons
and DP cases were often seen in isolation, interfering with
credible Case Definitions. Assembling even this small
number of candidate patients into a series with verified
datapoints,shouldatleast improved diagnosisconsistency.
Case Series Data Collection
The study protocol was simply a collection of clinical data
obtainedfromnewMorgellonsdiseasepatientsatoneclinic
in a two-hour session between September 2006 and July
2007. Patients were not solicited but came self-diagnosed.
Practicesizelimitedtheoriginalpatientnumberto30adults.
The final number was 25 after filtering for consistency and
data errors. Each clinical session included a detailed history,
review of systems and a physical examination emphasizing
dermal, neurological, endocrine and psychiatric systems.
Expanded laboratory tests included a blood count (CBC), a
metabolic panel (CMP) and others to evaluate major organ
system function to characterize immune status, detect
inflammation and search for an initial and limited number
of possible infectious pathogens suggested by several
veterinarians [personal communication].
Subjective screening criteria derived from earlier clinical
encounters were first applied to improve patient selection
consistency (Table 1). The screened data were then entered
into 492 fields on each patient, 407 fields of which
contained useful data points. This provided 10,175 total
parameters for analysis.
Case Series Initial Data Summary
The first-level summary of raw data is in the Appendix,
Tables A, B and C. Categories devoid of entries had no
significant findings.
Table 1. Initial Patient Screening Criteria
1. Patient convinced of chronic parasite infestation.
2. Primary patient illness focus must be either on dermal sensations or on
“never-before-seen” material thought to be extruded from his or her
body, even if this was not the most debilitating symptom or sign. The
material must have been described as “fibers”, “fiber-like”,o r“filaments”.
3. Chronic pruritis (itching) must have been present for at least six
months.
4. The patient must have at least two chronic, unhealed skin lesions
recorded by a clinician, regardless of whether excoriation was suspected.
5. Prior diagnosis of Delusions of Parasitosis or bipolar illness would not
exclude the patient as a candidate.
6. Patients experiencing delusional states common in withdrawal from
drugs such as opiates and patients in organic brain states, were excluded.
7. The illness must have had a life-altering effect on the patient.
8. The patient must be an adult and had experiencing symptoms for more
than six months.
9. A healthy pre-morbid period in the patient’s life was acceptable.
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Male and female rates were the same for those who
believed they had Morgellons disease. Age spread, geo-
graphic spread and gender neutrality were large. Thesedata
suggest Caucasian bias that did not appear in data from
other countries [11].
B. Illness History
Rural residence or recent rural travel was common.
Emotional stress was not relevant, nor was season of
onset. Physical stress was a common precursor. Full onset
typically required one to several months from first
symptom.
C. Past Medical History
Prior psychiatric diagnoses in more than half. The most
common diagnosis was bi-polar illness.
D. Social History
Significantly reduced exercise capacity was highly pre-
valent although non-specific as an illness marker. Recent
exposure to unhygienic settings (Third world countries,
sewage systems and land fills) correlated strongly with
illness onset.
E. Systems Information from physical examination and History of
Present Illness
General: Weight gain after illness onset averaged to 33
pounds.Highlevelsoffatigueandreducedexercisecapacity
were eventually present in 80% of patients. Recurrent fever
by thermometry was noted by 50% of patients.
Dermatological: A typical phrase used by most patients
was similar to: Extruding and moving skin “parasites”
(filaments, “fibers”, “spheres”) generating uncomforta-
ble lesions. Patients stated “filament” appearance was
intermittent and consistent with identifying in less than
one in three patients on examination. The sensation of
movement, however, was denied by up to 50% of those
experiencing filament extrusions. About 70% had
regular appearance of painful shallow skin ulcers, but
most could easily separate excoriations (scratching) they
had generated from spontaneous ulcers. Numerous
micro-angiomas (0.5 to 3.0 mm in diameter) were
found by examination on 72% of patients. This
phenomenon is a known hallmark of Bartonellosis,
although our patients had completely negative Barto-
nella serology [12,13]. Many patients noted that
angiomata appearance directly paralleled illness onset
and progression.
Central Nervous System: This group experienced a high
rate of headaches, visual aberrancies, tinnitus, and short-
term memory deficits. Emotional lability was present in
more than half, typically manifest intermittently.
Cardiovascular: Patients often reported orthostatic intol-
erance and frequent arrhythmias (type undetermined)
regardless of age. Rhythm and mild cardiac auscultation
abnormalities (valvular) were commonly found on vital
sign determination. Pulse was high (>72) in virtually all.
Psychiatric: Strikingly, most patients in this study (23 out
of 25) had prior psychiatric diagnoses (most determined
by specialists) as follows: 11 out of 25 bipolar disease; 7
out of 25 Adult ADD; 4 out of 25 Obsessive Compulsive
Disorder (OCD); and 1 out of 25 Schizophrenia. Although
overlap occurred in 5 cases, only the primary psychiatric
diagnosis was tabulated [14]. In each case, medical records
indicated that the dermal symptoms and signs preceded or
occurred simultaneously with the onset of emotional
signs, with an emotionally “normal” time in each patient’s
life prior to Morgellons disease.
Endocrine: Eight patients (32%) had prior diagnoses of
Hashimoto’s Thyroiditis. [The U.S. adult prevalence rate
of Hashimoto’s Thyroiditis is 0.56%. The rate is based
on 1996 statistics: 1,490,371 adults with Hashimoto’s
Thyroiditis per U.S. population of 264,162,000. (Refer-
ence: Rose and Mackay, 1998, The Autoimmune Diseases,
Third Edition)] Half had past evidence of Hypercalcemia
(intermittent), of which 3 had definite parathyroid
adenomas, later surgically excised with incomplete
improvement. Fasting insulin levels were elevated in
100% who were tested for it (6 out of 25), as were CRH
levels (also 6 out of 25 tested).
Other: Recurrent cough and dyspnea were common as GI
and urinary symptoms, but none had a recent medically
determined etiology.
F. Vital Signs
The most Consistent markers in this group were low core
temperature and high resting heart rate, affecting all
25 patients.
G. Laboratory Data
CBC aberrancies were common but often intermittent.
They included abnormal variable RBC indices, occasional
low-grade anemia, low white cell count, and high
monocyte count. Other abnormalities included low
Natural Killer cell (CD56 + CD16) number and percen-
tage, high or high-normal insulin level (in all tested) and
intermittent elevation of serum calcium, globulin level,
and A/G ratio. Sedimentation rate was mid-range
“normal” or lower with only one ANA positive. Anti-
double stranded DNA antibody level was negative in all
tested. Occasionally IgG subclasses 1 and 3 were low.
Commonly elevated markers supporting chronic inflam-
mation included C-reactive protein and TNF-alpha. Other
occasionally abnormal laboratory parameters present in
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Homocysteine and serum Leptin. Most patients showed
serologic evidence of infection (antibodies) with one or
more unexpected potentially pathogenic microorganisms
despite testing for only a few species.
Data Summary
Following is the concluding summary of collected data
from all patients, including pathological mechanisms
suggested by the pattern(s) of these data anomalies.
Morgellons disease was often preceded by exposure to
unhygienic conditions and appears first as skin abnorm-
alities and discomfort. Illness onset appears with moder-
ately rapid transition (weeks) from healthy to unhealthy,
including “emotional discomfort”. These gravid Morgel-
lons females had an extraordinarily high miscarriage rate.
The most common physical abnormalities found in this
series include: 1) Numerous “senile angiomas” on the
trunk, head and limbs of many; 2) Recurrent fever; 3)
Awareness of itching, crawling, stinging or biting. When
present, patients describe a circadian tempo to the
symptoms; some occurring solely at night. Itching of
unbroken skin specifically appeared to precede all other
skinsymptoms;4)Unidentifiedobjects(called“filaments”
or “granules”) “extrude” uncomfortably from unbroken
skin or skin lesions; 5) Painful ulcer-like concave, circular
skin lesions with distinct border; 6) Excoriations adjacent-
to but separate from ulcerations were common; 7) Dermal
symptoms were the central focus of discomfort for most
patients. 8. Multiple organ system symptoms often
appeared within the first six months of illness onset. The
most common systems affected were the central and
peripheral nervous systems, autonomic nervous system
then endocrine, cardiovascular, and pulmonary systems.
All blood pressures were low and all resting pulses were
high.
Routine laboratory tests were often inconsistent and varied
both positively and negatively, but within range more
frequently thanout of range. Common abnormalities were
NK cell numbers and percentages (low), and fasting
insulin levels (very high). Occasionally abnormal were
RBC indices, hematocrit, WBC count (low), monocyte
count (high), serum calcium (high), globulin level (high),
and A/G ratio (high).
Contradictory autoimmunity data was frequently noted.
Some expected inflammation tests such as sedimentation
rate and Anti-double stranded DNA antibody tests were
negative, while C-reactive protein and TNF-alpha were
routinely high. IFN-gamma, Homocysteine and Leptin
were also elevated. There was a high prevalence of
transient “autoimmune” diseases such as Hashimoto’s
Thyroiditis, hyperparathyroidism and adrenal-cortical
hypofunction.
Following is a second level summary of the Morgellons
data (Table 2). This is intended as a simplistic tool for
clinical use.
Conclusion
Proposed Characterization of Morgellons Disease
The authors conclude that Morgellons disease is a multi-
systemic illness that has been presumed as a delusional
phenomenon for decades as its most obvious and
disconcerting manifestations resembled actual (but
“unverified”) parasite infestation as well as various
psychopathologies. However, using recent technology
and even a modicum of consistently obtained physical
data supports that Morgellons manifest as a skin
phenomenon, an immune deficiency state and a chronic
inflammatory process. Since infectious agents can initiate
and maintain chronic diseases, the behavioral and other
CNS manifestations here are more likely effect than cause
[18]. We suggest that the Morgellons label be considered
to displace any label suggesting delusion as the primary
cause of this phenomenon.
The term “Morgellons disease” came into being in the 21
st
century in an attempt to identify an illness for which no
name existed. The entry of this new label into a
phenomenon of extreme controversy may at first appear
to further that controversy. Typical of the evolution of
medical nomenclature, however, the problem may always
have been with semantics; in particular the use of
assumptions unsupported from failure to investigate the
total physical patient [19].
The “index” case that failed to fit similar earlier diagnostic
labels was seen as “different” principally because its
observer looked beyond the presumed signs and symp-
toms of the truncated “look-alike” phenomenon labeled
“Delusions of Parasitosis”. Trabert’s review of 1,300+ cases
makes clear that only a fraction of the total signs of that
presumed illness were used to create the DP diagnostic
framework [14,20].
Our attempt to gather as much physical evidence on
Morgellons patients as possible was based on the
extremely large number of abnormal physical signs
among those we evaluated earlier. We gathered as many
clinical parameters as possible (within the fiscal con-
straints of “today’s” medicine) in order to see whether the
abnormalities among them were consistent and if so,
whether their pattern was explanatory. The unfolding
mechanism strongly suggests a chronic infectious process.
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until evidence of their presence is available and their
presence can explain the signs and symptoms we now find
in all Morgellons patients.
There remains considerable work to do in collecting more
data from these patients to create a credible Morgellons
disease Case Definition. We submit that the same holds
true for Delusions of Parasitosis patients [3]. Much of that
work may be now under way by the U.S. Centers for
Disease Control and Prevention (CDC) through contract
with Kaiser Permanente’s Northern California Division of
Research. [http://www.cdc.gov/unexplaineddermopathy/]
Meanwhile, the consistent abnormal findings in the data
above may be used to improve clinical diagnosis and
possibly initial treatment in current patients.
Perhaps of considerable importance to a journal dedicated
to Case Reports is what the juxtaposition of Morgellons
disease and Delusions of Parasitosis suggests. As noted by
Trabert in his meta-analysis, creating a Case definition
primarily from isolated cases allows uncontrolled use of
assumptions that vary considerably in order to keep an
unresolved conclusion constant. Where many cases are
used, consistency of similar data forces a far more valid
and consistent conclusion [14,20].
Until the machinery of science is in full gear and provides
understanding of this phenomenon, simply “paying
attention”, maintaining skepticism, practicing a simple
physical exam and using commercial laboratories judi-
ciously must suffice. Once the breadth and severity of what
we are encountering is understood, the resources and
motivation for its solution should come. When sufficient,
we anticipate the framework of several medical specialties
may be modified.
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Table 2. Primary Abnormal Findings
1. The large age spread, geographic spread and gender neutrality among patients suggest broad human susceptibility to the illness.
2. Rural abode or exposure to unhygienic conditions (third world travel or simply soil exposure) may be risk factors.
3. Onset rate is moderately rapid, without recognizable prodrome, commonly preceded by a healthy state.
4. Once ill, exercise capacity is significantly reduced.
5. The illness is common among family members and close associates, both related genetically and unrelated (such as spouses).
6. Most patients experience weight gain after disease onset.
7. Micro-angiomas appear rapidly on skin after illness onset in most.
8. Fever is recurrent in at least half of those affected.
9. The first illness sign may be the sudden appearance of persistent itching. Ulcerative lesions follow in some cases.
10. Once dermal symptoms begin, patients experience extrusion of unfamiliar material described variously as filamentous, “fuzz balls”, black or white
“flecks” or “rice grains”.
11. Numerous CNS effects occur, that includes bizarre cranial nerve phenomena, anxiety and emotional sequelae. The former tend to be transient.
12. Numerous Peripheral Nervous System findings appear after illness onset. Unlike CNS effects, these are serious, permanent and progressive, and include
sensory and motor nerves.
13. All Morgellons have elevated heart rate (>72 BPM) and low body temperature by oral thermometry (<97.5 degrees F).
14. Orthostatic intolerance is intermittent but common in most.
15. Most have some formally diagnosable emotional illness that begins with or becomes apparent after Morgellons disease onset.
16. Endocrine abnormality number and type is higher than background. Most common are Diabetes Type II, Hashimoto’s Thyroiditis, hyperparathyroidism
and adrenal hypofunction.
17. Most have elevated fasting insulin levels accompanied by elevated TNF-alpha (insulin receptor blocker) [15,16].
18. Common clinical laboratory abnormalities include:
a. RBCs have abnormal morphology. On manual examination, RBCs were non-discoid, varied in color and size.
b. Natural Killer Cell (CD 56 + CD 16) number and function are very low in most.
c. A/G ratio and globulin level are frequently elevated.
d. Sedimentation Rate and ANA are extremely low despite other common autoimmune-like conditions.
e. Elevated cytokines include: TNF-alpha, IFN-gamma, IL-6, C Reactive Protein, Homocysteine and serum Leptin.
19. Despite no fact-based Case Definition of Delusions of Parasitosis (DP), each of our 25 patients could have been given such an illness label as well. As
pointed out by Trabert in a meta-analysis of 1,223 DP cases and others, most DP data were taken from isolated cases. Psychiatric-skewed labels were
common such as “psychocutaneous disease”, “acarophobia” and “monosymptomatic hypochondriasis” with no serious search for consistent physical
abnormalities or microscopic parasitic agents [17].
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APPENDIX
TABLES OF RESULTS
NOTE: These tables are a first level summary of the complete
basicdatasetexceptforphysicalexaminationfindingsthatare
summarized above. Although subjectivity has been intro-
duced, we have attempted to keep it separate as footnotes.
Table A. Basic Background Data
Demographics Countries of origin: U.S., U.K., Canada, Japan Past medical history 11out of 25 were diagnosed with bipolar disease‡
Male: Female ratio approximates 50:50† 7 out of 25 were diagnosed with adult ADD‡
Age range: 10-75 years† 1 out of 25 was diagnosed with schizophrenia‡
24/25 were Caucasian
1
Urban: Rural ratio = 50:50†
2
Common childhood illnesses were absent
regardless of vaccination status†
19 out of 25 had been given general anesthesia at
least once*
9 out of 25 had prior orthopedic surgery*
6 out of 25 had other prior surgery for chronic
inflammatory diseases (appendix, gallbladder)*
Illness History Time from initiation to full onset: several months† Social History 50% were married/ 50% single*
Exposure to unhygienic conditions occurred several days
to several weeks prior to illness onset†
28% were smokers*
None routinely exercised*
Patients claimed relative healthiness prior to Morgellons
(as initially described) onset; No consistent recognized
prodrome heralded onset of the illness†
Allergy symptoms were rare†
Activating stressor event was present in 1 out of 3 of cases.
† Highest relevancy results.
‡ Findings that may help to isolate, identify, and define Morgellons disease.
* Other data.
1 This sample was not adequate to determine whether race is a factor. The high percentage of Caucasian patients was likely related to clinic location. Earlier
and subsequent data of larger numbers from more heterogeneous regions suggest that race is likely not a risk factor.
2 The urban to rural ratio may be significant. Although only 20% of people live in rural areas, 50% of the patient samples were in rural regions near the onset
of their illness, lending support to the hypothesis that exposure to unhygienic conditions or animals may be a risk factor.
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Dermatologic 24% of patients had dark filaments visibly protruding
from the skin‡
1
17 out of 25 had frequent skin eruptions/rashes†
Central Nervous
System
Over half had frequent headaches†
Over half had unstable visual acuity including double vision
(10 out of 25)†
Just over 50% experienced no movement sensations†
Only 50% itched regularly†
72% has angiomata appear
10 out of 25 reported visual “flashes” (not
characterized) in either daylight or dark†
Emotional liability in half of patients
1/3 reported frequent dizziness
Metabolic Average weight gain after onset: 33 lbs†
2
20 out of 25 experienced regular high levels of
fatigue†
1/3 reported permanent hearing loss (degree not
determined)
40% reported tinnitus
20 out of 25 reported frequent occurrence of forgetfulness
12 out of 25 had persistent regional skin numbness
6 out of 25 had persistent tremors
25% were intolerant to cold and 25% intolerant to heat
(some overlap, but degree undetermined)
10 out of 25 reported sweating inappropriately (either
under- or over-sweating)
Immune 12 out of 25 had cyclical fever† Endocrine 8 out of 25 had prior diagnosis of Hashimoto’s Thyroiditis
18 out of 25 reported numerous angiomas verified by
examination†
50% had hypercalcemia, 3 of whom had parathyroid
adenomas
10 out of 25 reported many “colds” annually* Fasting insulin levels were elevated in all tested (6 out of 25)
8 out of 25 reported “chronic sinusitis”*
4 out of 25 reported frequent sore throats over a
period of years*
2 out of 25 reported frequent toothaches*
Corticotrophin Releasing Hormone (CRH) levels were
elevated in all tested
Musculo-skeletal 15 out of 25 reported frequent neck pain†
10 out of 25 had persistent limited neck movement†
22 out of 25 had chronic musculoskeletal pain,
without arthritis‡
Pain was constant and incapacitating in 1/3 of
patients†
Gastro-intestinal
Pulmonary
50% had constipation or diarrhea, or both
(overlap was common)†
25% had chronic nausea†
Persistent cough (non-productive, non-wheezing) in
9 out of 25†
Persistent dyspnea in 7 out of 25
Emotional Half reported “anxiety” Other Urine stream control problems in 6 out of 25
Half reported frequent mood swings
Half reported frequent depression
1 Less than half of the 25 patients studied reported the presence of filaments, and as a result, the authors did not search for filaments on all patients.
2 Average weight gain in male and female patients combined. Time period for weight gain undetermined.
Table C. Vital Signs and Laboratory Data
Lab Parameters Laboratory Values
4
Vital Signs Average temp 97.51° F† WBC 6.76 (2.9-10.5)
Average pulse 85.32 BPM† RBC 4.89 (3.90-5.70)
HGB 16.36 (11.6-17.0)
Laboratory Data Unidentified lymphatic filamentous clusters were found in 4 patients‡ ABNL INDICES 28%†
5
50% were positive for Borrelia burgdorferi sensu lato either by CDC Western
Blot (WB) criteria, EUCALB WB (IgM P31 and 34 added), or IFA
1
% SEGS 58.2‡
6
4 patients were seropositive for Babesia microti
2
% MONOS 6.89‡
8
92% were seropositive for Chlamydia pneumonia (Chp)‡
3
% EOS 1.85
NK# (CD56/57) 71.85‡
9
NK% (CD56/57) 11.2‡
GLU (RANDOM) 97.95 (Random range 73-99) ‡
10
BUN 13.57 (9-26)
CREAT 0.86 (0.3-0.9)†
11
SODIUM 141.65 (137-146)
CHLORIDE 105.09 (96-111)
CO2 26.09 (22-31)
12
CALCIUM 9.65 (8.8-10.3)
13
T. PROT 7.32 (6.2-8.2)
ALBUMIN 4.68 (3.7-5.0)†
14
GLOBULIN 3.7 (2.2-3.5)†
15
A/G RATIO 2.63 (1.2-2.0)†
16
(Continued)
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17
AST 28.73 (17-49)
ALT 30.95 (12-46)
SED RATE 11.39 (0-20)
18
ANA (POSITIVE) 1
ADSDNA-AB
(POSITIVE)
0
ONE LOW IgG
SUBCLASS
4
TSH 2.14 (0.4-4.5)
19
ATA POS 0
IL-1A 51.2 (25-150)
HIV POS 1
CRP 3.44 (< 0.81 mg/dL)†
20
IL-1B 113.83 (< 150)
21
IL-6 3.48 (0-3.6)
22
TNF-a 16.92 (0-8.1)
23
TGF-b 108 (0 -100 pg/dL)
24
LEPTIN 13.66 (0.7-5.3 M)
25
1 Suggests Borrelia may contribute to some cases of Morgellons disease.
2 Suggests Babesia is uncommon in most Morgellons disease cases.
3 Suggests Chlamydia pneumonia (Chp) is one candidate for the initial etiology of Morgellons disease via generation of an immunodeficiency state.
4 Lab tests were drawn at 6,100 feet MSL (above mean sea level).
5 RBC characteristics were adjusted for elevation. All indices should be “normal.”
6 Lower than regional mean of 66%.
7 Slightly higher than regional mean of 28%.
8 Much higher than regional mean of 3.0%.
9 Although a broad “normal” range exists for NK number, our clinical experience supports that consistently healthy individuals who rarely experience viral
syndromes have NK # > 200. Our patients’ range is not infrequently below 10. This suggests one component of an immune deficiency state.
10 Well above regional mean of 84.
11 Well above regional mean of 0.6.
12 Although clearly “within range” at 6,100 ft. MSL, the mean of more than 100 similar patients tested near sea level (2001-2004) was 18 (21-28 anticipated).
As low CO2 level translates to low serum bicarbonate level, this suggests required buffering to lower acidity. Although there are several causes of elevated
serum acidity, many of these patients underwent overnight studies for sleep apnea that revealed consistent low breathing rate raising PCO2. No such formal
test was included in testing these patients although we believe such testing would be highly revealing.
13 Despite this average being satisfactory, 7 of the 25 patients tested were between 10.0 and 10.6. Three of 25 patients were found to have parathyroid
adenomas.
14 Greater than 5.0 in 9 of 25.
15 The converse of immune deficiency, however, suggests that a possible chronic infectious state may have been operant that could intermittently activate
humoral immunity.
16 Commonly above 2.0. As globulin is elevated and albumin is clearly not low, the ratio elevation is driven somehow by the albumin. This is presently a
paradox.
17 Average is high normal and well above the regional mean of 68. Suggests skeletal involvement in the disease, although liver involvement is possible. Most
Morgellons patients have shown evidence of osteopenia or osteoporosis when randomly tested despite age. Bone density was not determined in these 25
patients. We believe doing so would be valuable.
18 Argues against an autoimmune role, particularly as 5 out of 25 were 0, and all were less than 20.
19 Despite this normal finding, Hashimoto’s Thyroiditis is common in larger similar groups of Morgellons. Further evaluation of the HP axis and the
endocrine system in general should be included in any future studies.
20 Currently used to assess cardiac risk in three stages. In this context, we are assessing chronic inflammation. This average supports the presence of a
persistent inflammatory process that parallels physical evidence of vasculitis.
21 Five >150, suggests cytokine activation and possible inflammatory effect.
22 High-normal. 11 out of 25 >3.6, suggests cytokine activation and possible inflammatory effect.
23 Definite elevation in 92%. Most commonly corresponds to insulin receptor blockade and to chronic inflammatory effects.
24 Elevation of Transforming Growth Factor beta (TGF-beta) can occur when pathological events diminish its protective growth modulating effects on
various tissues. This test result parallels evidence of excessive growth processes observed in these patients such as numerous angiomata, skin tags, nevi, and
regions of increased epidermis density.
25 Consistently elevated in most male and female study patients. Parallels the gain in body fat and angiogenesis experienced by most following illness onset.
Table 4. (Continued)
Lab Parameters Laboratory Values
4
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